2月24日,康臣药业(01681)发布公告,自2025年2月24日起,董事局成员及财务总监发生变动。公告中提到,独立非执行董事陈玉君辞任,并不再担任审计委员会、提名委员会、薪酬委员会及环境、社会及治理委员会的成员。同时,李灼光被任命为新的独立非执行董事及审计委员会主席,接替陈玉君的职位。此外,方培城不再兼任财务总监职务,继续担任集团副总裁。陈玉君被任命为新的财务总监。陈玉君自2019年5月31日起...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.